Fluimucil Mucolytic Expectorant Syrup 600 Mg-15 Ml

Fluimucil Mucolytic 600 mg/15 ml is an ideal syrup for treating respiratory ailments characterized by thick and viscous hypersecretion .

Fluimucil Mucolytic Syrup is an over-the-counter mucolytic expectorant drug based on N-acetylcysteine. This active ingredient helps dissolve phlegm and eliminate mucus present in the respiratory tract , improving breathing. The syrup can be used in case of a wet cough or in case of an increase in the production of thick and viscous mucus .

Dosage and method of use of Fluimucil Mucolytic Expectorant Syrup 600 Mg-15 Ml

Adults : Take one 15 ml measuring cup of Fluimucil Mucolytic Syrup a day, preferably in the evening.
Before use, shake the bottle. Next, pour 15ml of syrup into the measuring cup. Once opened, the syrup is valid for 15 days.

Active Ingredients and Excipients Fluimucil Mucolitoco 600 mg/15 ml

Active ingredient : Active ingredient N-acetylcysteine ​​600 mg Excipients with known effects: methyl para-hydroxybenzoate, propyl para-hydroxybenzoate, sodium, sorbitol
Excipients : Methyl parahydroxybenzoate, Propyl parahydroxybenzoate, Sodium edetate, Carmellose, Saccharin sodium, Grenadine flavour, Strawberry flavour, Sorbitol, Sodium hydroxide, Purified water.

Contraindications Fluimucil Mucolitoco 600 mg/15 ml

The syrup is contraindicated in case of:

• Hypersensitivity to the active substance or to any of the excipients and to other closely related substances from a chemical point of view.
• Children under the age of 2.
• Generally contraindicated in pregnancy and breastfeeding.

Side effects Fluimucil Mucolitoco 600 mg/15 ml

The adverse reactions that occurred after taking N-acetylcysteine ​​orally are reported below. For details, refer to the leaflet:

• Immune system disorders: hypersensitivity Anaphylactic shock, anaphylactic/anaphylactoid reaction
• Nervous system disorders: headache
• Ear and labyrinth disorders: Tinnitus
• Cardiac disorders: tachycardia
• Vascular disorders: haemorrhage
• Respiratory, thoracic and mediastinal disorders: Bronchospasm, dyspnoea Bronchial obstruction
• Gastrointestinal disorders: Vomiting, diarrhoea, stomatitis, abdominal pain, nausea, dyspepsia
• Skin and subcutaneous tissue disorders: Urticaria, rash, angioedema, pruritus
• General disorders and administration site conditions: Pyrexia Face oedema
• Investigations: Reduced blood pressure

Overdose Fluimucil Mucolitoco 600 mg/15 ml

No cases of overdose have been reported with regard to oral administration of N-acetylcysteine. Healthy volunteers who took a daily dose of 11.6 g of N-acetylcysteine ​​for three months did not experience any serious adverse reactions. Doses up to 500 mg NAC/kg body weight, administered orally, were tolerated without any symptoms of intoxication. Overdose can cause gastrointestinal symptoms such as nausea, vomiting and diarrhea. There are no specific antidotal treatments; overdose therapy is based on symptomatic treatment.

Special warnings Fluimucil Mucolitoco 600 mg/15 ml

Patients suffering from bronchial asthma must be closely monitored during therapy, if bronchospasm appears the treatment must be stopped immediately. Mucolytics can induce bronchial obstruction in children younger than 2 years. In fact, the drainage capacity of the bronchial mucus is limited in this age range, due to the physiological characteristics of the respiratory tract. They should therefore not be used in children younger than 2 years of age.

The use of the medicine in patients suffering from peptic ulcer or with a history of peptic ulcer requires particular attention, especially in the case of simultaneous intake of other drugs with a known gastrolesive effect. The possible presence of a sulfurous odor does not indicate alteration of the preparation but is typical of the active principle contained in it. The administration of N-acetylcysteine, especially at the beginning of the treatment, can thin the bronchial secretions and at the same time increase their volume.

If the patient is unable to expectorate effectively, postural drainage and bronchoaspiration must be used to avoid retention of secretions. Important information about some of the excipients The syrup contains parahydroxybenzoates which can cause allergic reactions of the delayed type and, more rarely, immediate reactions with bronchospasm and urticaria. The 600 mg/15 ml syrup contains sorbitol therefore patients with rare hereditary problems of fructose intolerance should not take this medicine.

The 600 mg/15 ml syrup contains 96.6 mg sodium per 15 ml dose. The amounts of sodium should be taken into account in the case of patients with impaired renal function or who follow a low sodium diet.

Pregnancy and lactation Fluimucil Mucolytic Expectorant Syrup 600 Mg-15 Ml

Can I take Fluimucil Mucolytic 600 Mg-15 Ml when pregnant or breastfeeding?

Fluimucil Mucolytic has not shown any teratogenic effect, however, as for other drugs, its administration during pregnancy and during the breastfeeding period should be carried out only in case of real need under the direct supervision of the doctor.

Expiration and conservation of Fluimucil Mucolytic Expectorant Syrup 600 Mg-15 Ml

How to store Fluimucil Mucolytic 600 Mg-15 Ml

Store at a temperature not exceeding 30°C. Once opened, the syrup has a maximum validity of 15 days.